Transplantation Dose Alters the Differentiation Program of Hematopoietic Stem Cells.

ABSTRACT: Hematopoietic stem cell (HSC) transplantation is the most prevalent stem cell therapy, but it remains a risky procedure. To improve this treatment, it is important to understand how transplanted stem cells rebuild the blood and immune systems and how this process is impacted by transplantation variables such as the HSC dose. Here, we find that, in the long term following transplantation, 70%-80% of donor-HSC-derived clones do not produce all measured blood cell types. High HSC doses lead to more clones that exhibit balanced lymphocyte production, whereas low doses produce more T-cell-specialized clones. High HSC doses also produce significantly higher proportions of early-differentiating clones compared to low doses. These complex differentiation behaviors uncover the clonal-level regenera

SUBMITTER: Brewer C 

PROVIDER: S-EPMC4880538 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature